GSA Capital Partners LLP bought a new position in shares of Envista Holdings Corporation (NYSE:NVST - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 77,392 shares of the company's stock, valued at approximately $2,039,000.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Dimensional Fund Advisors LP increased its holdings in shares of Envista by 1.6% in the first quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company's stock worth $248,130,000 after purchasing an additional 152,488 shares during the period. Alliancebernstein L.P. boosted its stake in Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company's stock valued at $119,164,000 after buying an additional 1,547,656 shares during the period. Arrowstreet Capital Limited Partnership grew its position in Envista by 341.5% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company's stock worth $72,515,000 after buying an additional 2,210,847 shares in the last quarter. Quantinno Capital Management LP grew its position in Envista by 38.8% during the first quarter. Quantinno Capital Management LP now owns 2,694,970 shares of the company's stock worth $68,371,000 after buying an additional 753,474 shares in the last quarter. Finally, Millennium Management LLC increased its stake in Envista by 1,442.7% in the 4th quarter. Millennium Management LLC now owns 2,420,615 shares of the company's stock worth $52,552,000 after acquiring an additional 2,263,712 shares during the last quarter.
Envista Stock Performance
Shares of NYSE NVST opened at $28.05 on Friday. The stock has a market cap of $4.50 billion, a price-to-earnings ratio of 48.35, a P/E/G ratio of 1.34 and a beta of 0.86. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. Envista Holdings Corporation has a 1-year low of $18.77 and a 1-year high of $30.42. The stock's 50-day moving average is $26.57 and its 200 day moving average is $26.15.
Envista (NYSE:NVST - Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.07. The business had revenue of $730.50 million during the quarter, compared to analyst estimates of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.Envista's revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.26 earnings per share. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, sell-side analysts anticipate that Envista Holdings Corporation will post 1.53 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on NVST. BMO Capital Markets started coverage on Envista in a research report on Wednesday, July 8th. They set a "market perform" rating and a $27.00 price target for the company. Piper Sandler restated a "neutral" rating and issued a $28.00 price objective (up from $26.00) on shares of Envista in a research report on Thursday, August 6th. Wall Street Zen downgraded shares of Envista from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 9th. Weiss Ratings upgraded shares of Envista from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, August 6th. Finally, Robert W. Baird set a $34.00 price target on shares of Envista in a research note on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $29.31.
Check Out Our Latest Analysis on NVST
Envista Profile
(
Free Report)
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company's offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista's product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Featured Articles
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.